GRIN1/NMDAR1 Anticorps
(Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1 (GRIN1))
Choisissez l’un des 228 anticorps GRIN1/NMDAR1 de notre liste de produits basés sur 16 publications et 99 images de validation.
Découvrez des anticorps GRIN1/NMDAR1 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de GRIN1/NMDAR1 dans plusieurs espèces, y compris Human, Rat, Mouse, Dog, Xenopus laevis, Chicken, Cow, Monkey, Zebrafish (Danio rerio), Non-Human Primate, Pig, Drosophila melanogaster, et prend en charge diverses applications de recherche telles que WB, IHC, ELISA, IF (cc), IF (p).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants GRIN1/NMDAR1, issus de différents hôtes tels que Rabbit, Mouse, Chicken. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de GRIN1/NMDAR1 sont GRIN1, grin1.S, grin1, Grin1, Nmdar1, Gprin1, grin1a.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| GRIN1/NMDAR1 anticorps (AA 831-930) (AbBy Fluor® 647) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (AbBy Fluor® 680) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (AbBy Fluor® 488) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (AbBy Fluor® 555) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (Cy3) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (FITC) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (Cy5) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (Cy5.5) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (Cy7) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (AA 831-930) (HRP) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| Recombinant GRIN1/NMDAR1 anticorps | Humain | Lapin Monoclonal |
|
1.006,50 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (AbBy Fluor® 350) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (AbBy Fluor® 594) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (AbBy Fluor® 647) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (AbBy Fluor® 488) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (AbBy Fluor® 555) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (AbBy Fluor® 680) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer896) (AbBy Fluor® 647) | Humain | Lapin Polyclonal |
|
426,37 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (Cy5) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
|
| GRIN1/NMDAR1 anticorps (pSer890) (Cy5.5) | Humain | Lapin Polyclonal |
|
437,53 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 647
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 680
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 488
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 555
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy5
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy5.5
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy7
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- HRP
- Isotype
- IgG
- Epitope
- AA 831-930
Primary Antibody
- FACS (Flow Cytometry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Monoclonal
- Clone
- 24F524F5
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 350
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 594
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 647
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 488
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 555
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 680
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- AbBy Fluor® 647
- Isotype
- IgG
- Epitope
- pSer896
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy5
- Isotype
- IgG
- Epitope
- pSer890
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy5.5
- Isotype
- IgG
- Epitope
- pSer890
Dernières publications pour nos GRIN1/NMDAR1 Anticorps
: "Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities." dans: Disease models & mechanisms, Vol. 12, Issue 2, (2019) (PubMed).
: "Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons." dans: JCI insight, Vol. 5, (2019) (PubMed).
: "Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. ..." dans: Nature medicine, Vol. 24, Issue 3, pp. 313-325, (2018) (PubMed).
: "2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor." dans: Journal of cellular physiology, (2017) (PubMed).
: "Pharmacological inhibition of PTEN attenuates cognitive deficits caused by neonatal repeated exposures to isoflurane via inhibition of NR2B-mediated tau phosphorylation in rats." dans: Neuropharmacology, Vol. 114, pp. 135-145, (2017) (PubMed).
: "Motor neuron degeneration following glycine-mediated excitotoxicity induces spastic paralysis after spinal cord ischemia/reperfusion injury in rabbit." dans: American journal of translational research, Vol. 9, Issue 7, pp. 3411-3421, (2017) (PubMed).
: "Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons: OPPOSING ROLES FOR THE TRANSCRIPTION FACTORS CREB (cAMP RESPONSE ELEMENT BINDING) PROTEIN AND Sp1 ..." dans: The Journal of biological chemistry, Vol. 291, Issue 53, pp. 27279-27288, (2016) (PubMed).
: "Mechanisms responsible for the effect of median nerve electrical stimulation on traumatic brain injury-induced coma: orexin-A-mediated N-methyl-D-aspartate receptor subunit NR1 upregulation." dans: Neural regeneration research, Vol. 11, Issue 6, pp. 951-6, (2016) (PubMed).
: "Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease." dans: Neurobiology of disease, Vol. 74, pp. 254-62, (2015) (PubMed).
: "Conantokin-G attenuates detrimental effects of NMDAR hyperactivity in an ischemic rat model of stroke." dans: PLoS ONE, Vol. 10, Issue 3, pp. e0122840, (2015) (PubMed).
: "Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons." dans: JCI insight, Vol. 5, (2019) (PubMed).
: "Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. ..." dans: Nature medicine, Vol. 24, Issue 3, pp. 313-325, (2018) (PubMed).
: "2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor." dans: Journal of cellular physiology, (2017) (PubMed).
: "Pharmacological inhibition of PTEN attenuates cognitive deficits caused by neonatal repeated exposures to isoflurane via inhibition of NR2B-mediated tau phosphorylation in rats." dans: Neuropharmacology, Vol. 114, pp. 135-145, (2017) (PubMed).
: "Motor neuron degeneration following glycine-mediated excitotoxicity induces spastic paralysis after spinal cord ischemia/reperfusion injury in rabbit." dans: American journal of translational research, Vol. 9, Issue 7, pp. 3411-3421, (2017) (PubMed).
: "Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons: OPPOSING ROLES FOR THE TRANSCRIPTION FACTORS CREB (cAMP RESPONSE ELEMENT BINDING) PROTEIN AND Sp1 ..." dans: The Journal of biological chemistry, Vol. 291, Issue 53, pp. 27279-27288, (2016) (PubMed).
: "Mechanisms responsible for the effect of median nerve electrical stimulation on traumatic brain injury-induced coma: orexin-A-mediated N-methyl-D-aspartate receptor subunit NR1 upregulation." dans: Neural regeneration research, Vol. 11, Issue 6, pp. 951-6, (2016) (PubMed).
: "Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease." dans: Neurobiology of disease, Vol. 74, pp. 254-62, (2015) (PubMed).
: "Conantokin-G attenuates detrimental effects of NMDAR hyperactivity in an ischemic rat model of stroke." dans: PLoS ONE, Vol. 10, Issue 3, pp. e0122840, (2015) (PubMed).
Pseudonymes pour GRIN1/NMDAR1 Anticorps
glutamate ionotropic receptor NMDA type subunit 1 (GRIN1) Anticorpsglutamate receptor, ionotropic, N-methyl D-aspartate 1 S homeolog (grin1.S) Anticorps
glutamate ionotropic receptor NMDA type subunit 1 (grin1) Anticorps
glutamate ionotropic receptor NMDA type subunit 1 (Grin1) Anticorps
NMDA receptor 1 (Nmdar1) Anticorps
G protein-regulated inducer of neurite outgrowth 1 (Gprin1) Anticorps
glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1) Anticorps
glutamate receptor, ionotropic, N-methyl D-aspartate 1a (grin1a) Anticorps
GB19253 Anticorps
GluN1 Anticorps
GluRdelta1 Anticorps
GluRzeta1 Anticorps
GRIN1 Anticorps
M100174 Anticorps
MRD8 Anticorps
NMD-R1 Anticorps
NMDA1 Anticorps
nmda1 Anticorps
Nmdar Anticorps
NMDAR1 Anticorps
nmdar1 Anticorps
NMDAR1.1 Anticorps
NR1 Anticorps
Rgsc174 Anticorps
Z16 Anticorps
zgc:152678 Anticorps
Avez-vous cherché autre chose?
- GRIK4 Anticorps
- GRIK3 Anticorps
- GRIK2 Anticorps
- GRIK1 Anticorps
- GRID2IP Anticorps
- GRID2 Anticorps
- GRID1 Anticorps
- GRIA2 Anticorps
- GRHL3 Anticorps
- GRHL2 Anticorps
- GRHL1 Anticorps
- GREM2 Anticorps
- GREM1 Anticorps
- GREB1 Anticorps
- GRB7 Anticorps
- GRB2-Related Adaptor Protein 2 Anticorps
- GRB2 Anticorps
- GRB14 Anticorps
- GRB10 Anticorps
- GRASP Anticorps
- GRIN2B Anticorps
- GRIN2C Anticorps
- GRIN2D Anticorps
- GRIN3A Anticorps
- GRIN3B Anticorps
- GRINA Anticorps
- GRIP1 Anticorps
- GRIPAP1 Anticorps
- GRK1 Anticorps
- GRK2 Anticorps
- GRK4 Anticorps
- GRK5 Anticorps
- GRK6 Anticorps
- GRLF1 Anticorps
- GRM2 Anticorps
- GRM7 Anticorps
- GRM8 Anticorps
- GRO gamma Anticorps
- Growth Arrest and DNA-Damage-Inducible, beta Anticorps
- Growth Arrest-Specific 1 Anticorps
Vous êtes ici:
